hyaluronoglucosaminidase has been researched along with Atheroma in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Annibali, G; Crea, F; D'Aiello, A; Flego, D; Giglio, AF; Liuzzo, G; Niccoli, G; Pedicino, D; Piacentini, R; Pisano, E; Porto, I; Ruggio, A; Russo, G; Trotta, F; Vergallo, R; Vinci, R | 1 |
| Binder, RK; Crea, F; Lüscher, TF; Widimsky, P | 1 |
| He, J; Jiang, C; Liu, J; Wang, Z; Yang, Y; Zhang, M; Zhang, W | 1 |
1 review(s) available for hyaluronoglucosaminidase and Atheroma
| Article | Year |
|---|---|
The year in cardiology 2018: acute coronary syndromes.
Topics: Acute Coronary Syndrome; Adaptive Immunity; Anticoagulants; Biomarkers; Carrier Proteins; Cell Adhesion Molecules; Diagnostic Techniques, Cardiovascular; Dual Anti-Platelet Therapy; Early Diagnosis; Gene Expression; GPI-Linked Proteins; Heart; Humans; Hyaluronan Receptors; Hyaluronoglucosaminidase; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Immunity, Innate; Magnetic Resonance Imaging, Cine; Myocardial Infarction; Oxygen Inhalation Therapy; Percutaneous Coronary Intervention; Plaque, Atherosclerotic; Risk Assessment; Rupture; Sex Factors; Stents; Takotsubo Cardiomyopathy; Troponin; Vascular Remodeling | 2019 |
2 other study(ies) available for hyaluronoglucosaminidase and Atheroma
| Article | Year |
|---|---|
Alterations of Hyaluronan Metabolism in Acute Coronary Syndrome: Implications for Plaque Erosion.
Topics: Acute Coronary Syndrome; Aged; Case-Control Studies; Cell Adhesion Molecules; Female; Gene Expression; GPI-Linked Proteins; Humans; Hyaluronan Receptors; Hyaluronoglucosaminidase; Leukocytes, Mononuclear; Male; Middle Aged; Plaque, Atherosclerotic; Protein Splicing; RNA, Messenger; Tomography, Optical Coherence | 2018 |
Plaque-hyaluronidase-responsive high-density-lipoprotein-mimetic nanoparticles for multistage intimal-macrophage-targeted drug delivery and enhanced anti-atherosclerotic therapy.
Topics: Animals; Cholesterol; Coculture Techniques; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Flow Cytometry; Human Umbilical Vein Endothelial Cells; Humans; Hyaluronic Acid; Hyaluronoglucosaminidase; Lactic Acid; Lipoproteins, HDL; Macrophages; Male; Mice; Nanoparticles; Particle Size; Plaque, Atherosclerotic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; RAW 264.7 Cells; Simvastatin; Static Electricity; Tunica Intima | 2017 |